Evidence map›Paper›PMID 31129775›Full record

Trial reportNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2019

Effect of verticalization with Erigo® in the acute rehabilitation of severe acquired brain injury.

Emilio Ancona, Annamaria Quarenghi, Marcello Simonini, Raoul Saggini, Stefano Mazzoleni, Antonio De Tanti, Donatella Saviola, Giovanni Pietro Salvi

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Emilio AnconaNeurorehabilitation Unit, "Quarenghi" Clinical Institute, Via San Carlo 70, 24016 San Pellegrino Terme, Bergamo, Italy.
Annamaria QuarenghiNeurorehabilitation Unit, "Quarenghi" Clinical Institute, Via San Carlo 70, 24016 San Pellegrino Terme, Bergamo, Italy.
Marcello SimoniniNeurorehabilitation Unit, "Quarenghi" Clinical Institute, Via San Carlo 70, 24016 San Pellegrino Terme, Bergamo, Italy.
Raoul SagginiSchool of Specialty in Physical and Rehabilitation Medicine, "Gabriele d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Stefano MazzoleniThe BioRobotics Institute, Scuola Superiore "Sant'Anna", Pontedera, Pisa, Italy.
Antonio De Tanti"Cardinal Ferrari" Rehabilitation Centre, "Santo Stefano" Riabilitazione, Fontanellato, Parma, Italy.
Donatella Saviola"Cardinal Ferrari" Rehabilitation Centre, "Santo Stefano" Riabilitazione, Fontanellato, Parma, Italy.
Giovanni Pietro SalviNeurorehabilitation Unit, "Quarenghi" Clinical Institute, Via San Carlo 70, 24016 San Pellegrino Terme, Bergamo, Italy. segreteriasan@clinicaquarenghi.it.
Ferrari (Italy) · ITScuola Superiore Sant'Anna · ITUniversity of Chieti-Pescara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recovery of the orthostatism after a severe acquired brain injury (sABI) is an essential objective to pursue in order to avoid the occurrence of secondary complications resulting from prolonged immobilization to which the patient is subjected during the acute phase. This randomized controlled trial aims to evaluate the effect of verticalization with the lower limb robot-assisted training system Erigo® versus conventional neurorehabilitation in 44 adult subjects affected by sequelae of sABI in the acute rehabilitation phase, related to cardiorespiratory signs and measures of impairment and activity. At the end of the study (20 treatment sessions, 5 sessions per week), in both groups of patients, there were no dropouts nor adverse events. In subject verticalized with Erigo®, there were no episodes of (pre)syncope from orthostatic hypotension nor postural orthostatic tachycardia and cardiorespiratory signs remained stable; moreover, there were no increase in muscle tone nor reduction in range of motion at lower limbs. Results obtained show improved outcomes on the whole and in a similar way in both groups; however, the improvement in scores of the National Institutes of Health Stroke Scale, the Tinetti scale, and the Functional Independence Measure from the enrollment to the end of the treatment cycle being equal, the evaluation performed at the 10th session allows to establish that the improvement appears earlier in the intervention group and later in the control group. The more rapid recovery of impairments and some activities in subjects treated with Erigo® could allow a "time-saver" to devote to the rehabilitation of sensory-motor functions which are more complex and subordinated to the preliminary reacquisition of elementary postures and motor strategies.

Indexed as

AdolescentAdultAgedAged, 80 and overBrain InjuriesFemaleHumansMaleMiddle AgedNeurological RehabilitationOrthostatic IntolerancePatient PositioningRoboticsYoung AdultAcute rehabilitationErigo®RoboticssABISevere acquired brain injuryVerticalization

Identifiers

PMID31129775
OpenAlexW2946074384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.